Sage Journals: Discover world-class research

Open access

Research article

First published 2021

The role of ixekizumab in non-radiographic axial spondyloarthritis

Bon San Koo, Tae-Hwan Kim

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2016-12

Successful Treatment of Recalcitrant Palmoplantar Pustulosis with Ixekizumab

Joseph Kamel, Ethan Routt

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Case report

First published 2024-8

Multiple Mucosal Ulcers Induced by Ixekizumab: A Case Report

Cheng Zheng, Xiao He, Xuxia Tang

Annals of Otology,Rhinology & Laryngology

Open access

Case report

First published 2025

Merkel cell carcinoma in a psoriasis patient on long-term ixekizumab therapy: A case report

Saba R. Malik, Thomas G. Salopek, John Walker [...]

Sage Open Medical Case Reports

Open access

Brief report

First published 2022-1

A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis

Saman Darabian, Maziar Badii, Jan P. Dutz [...]

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Case report

First published 2022-4

Use of ixekizumab in an HIV-positive patient with psoriatic arthritis

Feng Qian, Yujuan Yan, Jinlong Huang [...]

International Journal of STD & AIDS

Retricted access

Brief report

First published 2021-1

Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

Alexander L. Fogel, Bruce Strober

Journal of Psoriasis and Psoriatic Arthritis®

Retricted access

Research article

First published 2019-3

Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice

Jorge R. Georgakopoulos, Michelle Phung, Arvin Ighani [...]

Journal of Cutaneous Medicine and Surgery

Open access

Research article

First published 2019

Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy

Roberto Ravasio, Silvia Antonelli, Alessia Maiorino [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Retricted access

Case report

First published 2019-1

Success of the IL-17 Inhibitor Ixekizumab in a Case of Refractory Pediatric Psoriasis and a Summary of FDA-Approved Biologics for Moderate to Severe Pediatric Psoriasis Vulgaris

Nicola E. Natsis, Jacklyn Steixner, Alice B. Gottlieb

Journal of Psoriasis and Psoriatic Arthritis®

Search results